WSJ.com
Innovation in Target Validation Program
Led by Dr. Robert Rottapel at University Health Network, the objective
of the program is to develop and deploy technologies to accelerate the
identification and validation of new candidate targets against cancer,
particularly ovarian cancer, using state-of-the-art high-throughput
technologies.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.